Recently, Peng Yang, Vice President of Danaher Global Yang Peng visited Suzhou BioLihe. The two parties had an in-depth communication on the Danaher Business System (DBS) and BioLihe’s production and operation. With the support of Danaher DBS experts, BioLihe will set up an improvement team to continuously improve production efficiency.

In March this year, Beckman Coulter, a medical diagnostic company under Danaher, signed a strategic cooperation with BioLihe. The two parties will carry out deep cooperation in the field of immune testing, jointly create more complete and higher-quality diagnostic solutions for the local market, improve the accessibility of high-quality medical services, and then benefit more domestic patients.

KingMed and Xinhua Hospital to explore the clinical role of CTC liquid biopsy

In order to further strengthen the in-depth cooperation in the application of liquid biopsy technology and innovative scientific research, on July 1, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine and Guangzhou KingMed Diagnostics Group Co., Ltd. officially launched the standardized detection project of CTC (circulating tumor cell) liquid biopsy, which will play the important role of CTC detection in the evaluation of the efficacy of solid tumors, monitoring of recurrence and metastasis, and evaluation of prognosis, and help the precise diagnosis and treatment of solid tumors.

This cooperation will rely on the advantages of multi-technology platforms including sequencing platform, chromosomal microarray technology platform, fluorescence in situ hybridization platform, mass spectrometry platform, flow cytometry platform, immunohistochemistry platform, ultramicropathology platform and organoid platform.

In this way, CTC testing services and full-process scientific research services will be provided for clinical use, and clinical service capabilities will continue to be improved to help achieve true accurate diagnosis and treatment.